Bone Biologics Corporation

NasdaqCM:BBLG Stock Report

Market Cap: US$2.4m

Bone Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BBLG?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders9,7210.395%
Private Companies43,2211.75%
Institutions131,3755.33%
General Public2,279,21792.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 361.1%.

Top Shareholders

Top 16 shareholders own 7.48% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.75%
Ionic Ventures, LLC
43,088US$41.4k0%no data
1.33%
UBS Asset Management AG
32,851US$31.5k-2.54%no data
1.16%
Morgan Stanley, Investment Banking and Brokerage Investments
28,527US$27.4k0%no data
0.9%
Hudson River Trading LLC, Asset Management Arm
22,276US$21.4k27.2%no data
0.69%
Knight Insurance Company, Ltd, Investment Arm
16,942US$16.3k0%100.0%
0.63%
Geode Capital Management, LLC
15,592US$15.0k71.8%no data
0.4%
Sabby Management, LLC
9,877US$9.5k0%0.05%
0.23%
Don Hankey
5,695US$5.5k0%no data
0.11%
Hankey Investment Company, LP
2,663US$2.6k0%no data
0.087%
Jeffrey Frelick
2,151US$2.1k0%no data
0.076%
Deina Walsh
1,875US$1.8k0%no data
0.072%
Tower Research Capital Europe Limited
1,786US$1.7k-69.2%no data
0.018%
Carson Wealth Management Group
444US$426.20%no data
0.016%
MFA Wealth Advisors, LLC
403US$387.00%no data
0.0054%
AFH Holding & Advisory, LLC
133US$127.70%no data
0.00057%
Bank of America Corporation, Asset Management Arm
14US$13.555.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 12:49
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bone Biologics Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bradley SorensenZacks Small-Cap Research